China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers and acquisitions and independent development, build a modern supply chain system, strengthen the construction of digital e-commerce platforms, and comprehensively enhance the ability to serve global customers.
Company Background
Founded in 2005, BioScience has established partnerships with a number of high-profile companies, including Danaher, Thermo Fisher, and others. The company has been committed to providing comprehensive life sciences services and has continuously expanded its business scope and service capabilities.
Future Plans
With the support of this new round of financing, BioScience plans to further expand its product lines and enhance its supply chain management capabilities. The company will also focus on strengthening its digital e-commerce platform to better serve its global customer base. The funding will play a crucial role in supporting BioScience’s strategic development and market expansion.-Fineline Info & Tech
Leave a Reply